Ribomic Inc. (TYO: 4591)
Japan
· Delayed Price · Currency is JPY 84.00
+1.00 (1.20%)
Sep 27, 2024, 11:05 AM JST
Ribomic Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 1 | - | 65 | 80 | 91 | 121 | Upgrade
|
| Revenue Growth (YoY) | -98.41% | - | -18.75% | -12.09% | -24.79% | 1628.57% | Upgrade
|
| Gross Profit | 1 | - | 65 | 80 | 91 | 121 | Upgrade
|
| Selling, General & Admin | 349 | 352 | 361 | 313 | 304 | 319 | Upgrade
|
| Research & Development | 687 | 764 | 1,491 | 1,482 | 957 | 673 | Upgrade
|
| Other Operating Expenses | - | - | - | 34 | 69 | 42 | Upgrade
|
| Operating Expenses | 1,036 | 1,116 | 1,852 | 1,829 | 1,331 | 1,035 | Upgrade
|
| Operating Income | -1,035 | -1,116 | -1,787 | -1,749 | -1,240 | -914 | Upgrade
|
| Interest & Investment Income | 1 | 1 | 2 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 11 | 10 | 20 | 11 | -9 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 120 | 122 | 116 | 103 | 63 | 60 | Upgrade
|
| EBT Excluding Unusual Items | -903 | -983 | -1,649 | -1,635 | -1,186 | -854 | Upgrade
|
| Asset Writedown | -40 | -40 | -3 | -48 | - | - | Upgrade
|
| Pretax Income | -943 | -1,023 | -1,652 | -1,683 | -1,186 | -854 | Upgrade
|
| Income Tax Expense | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Net Income | -944 | -1,024 | -1,653 | -1,684 | -1,187 | -855 | Upgrade
|
| Net Income to Common | -944 | -1,024 | -1,653 | -1,684 | -1,187 | -855 | Upgrade
|
| Shares Outstanding (Basic) | 36 | 36 | 31 | 28 | 26 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 36 | 36 | 31 | 28 | 26 | 16 | Upgrade
|
| Shares Change (YoY) | 9.10% | 14.73% | 10.70% | 9.29% | 61.26% | 10.96% | Upgrade
|
| EPS (Basic) | -26.31 | -28.69 | -53.14 | -59.92 | -46.16 | -53.62 | Upgrade
|
| EPS (Diluted) | -26.31 | -28.69 | -53.14 | -59.92 | -46.16 | -53.62 | Upgrade
|
| Free Cash Flow | - | -954 | -1,731 | -1,509 | -1,150 | -948 | Upgrade
|
| Free Cash Flow Per Share | - | -26.73 | -55.64 | -53.70 | -44.72 | -59.45 | Upgrade
|
| Gross Margin | 100.00% | - | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -103500.00% | - | -2749.23% | -2186.25% | -1362.64% | -755.37% | Upgrade
|
| Profit Margin | -94400.00% | - | -2543.08% | -2105.00% | -1304.40% | -706.61% | Upgrade
|
| Free Cash Flow Margin | - | - | -2663.08% | -1886.25% | -1263.74% | -783.47% | Upgrade
|
| EBITDA | -1,023 | -1,106 | -1,787 | -1,734 | -1,214 | -897 | Upgrade
|
| D&A For EBITDA | 12.38 | 10 | 0.48 | 15 | 26 | 17 | Upgrade
|
| EBIT | -1,035 | -1,116 | -1,787 | -1,749 | -1,240 | -914 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.